NEW YORK (GenomeWeb News) – Exact Sciences will meet next week with officials from the Centers for Medicare and Medicaid Services to discuss the status of CMS’ review of the firm’s colorectal cancer screening technology, the company said today.
 
The company applied last August for a national coverage determination with CMS to try to get the stool-based CRC diagnostic covered under Medicare, but in October it was notified by the US Food and Drug Administration that the PreGen-Plus assay would require premarket approval.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.